<DOC>
	<DOC>NCT00688428</DOC>
	<brief_summary>The purpose of this study is to test if fixed dose esomeprazole and ASA capsule is pharmaceutically equal to a free combination of esomeprazole capsule and ASA tablet</brief_summary>
	<brief_title>Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Body mass index of 1929kg/m2, inclusive Weight of 5095kg, inclusive Clinically normal physical findings and laboratory values including hepatitis B, hepatitis C, and HIV, as judged by the Investigator Significant clinical illness within the 2 weeks preceding the first dose of investigational products, as judged by the Investigator History of mental, cardiac, renal, hepatitis, neurological, or significant gastrointestinal disease, as judged by the Investigator Condition which could modify the absorption of the investigational products, as judged by the Investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>esomeprazole</keyword>
	<keyword>upper gi symptoms</keyword>
	<keyword>low dose Aspirin treatment</keyword>
</DOC>